Drug intelligence / Profile preview

MEL-pep

Development stage
Preclinical
Modality
Peptides
Administration
Intratumoral
01

Overview

MEL-pep is a **synthetic peptide drug** that is a novel analog of the natural antibacterial peptide melittin, derived from bee venom. MEL-pep has been designed to disrupt cell membranes and has demonstrated potent anti-cancer activities, specifically against 5-fluorouracil-resistant human hepatocellular carcinoma (HCC) cells. It binds directly to tumor cell membranes, leading to membrane disruption and cell death, and reverses chemotherapy resistance primarily by inhibiting P-glycoprotein (P-gp) expression and deactivating the PI3K/Akt signaling pathway. In preclinical studies, intratumoral administration in mouse xenograft models suppressed tumor growth in a dose-dependent manner. MEL-pep shows promise as a targeted therapy for chemotherapy-resistant HCC[2][6].

Other names
MEL-pep
02

Targets

NF-κBABCB1 (P-glycoprotein)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on MEL-pep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEL-pep.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call